Unknown

Dataset Information

0

Cancer-attributable mortality among solid organ transplant recipients in the United States: 1987 through 2014.


ABSTRACT: BACKGROUND:Solid organ transplant recipients have an elevated risk of cancer. Quantifying deaths attributable to cancer can inform priorities to reduce cancer burden. METHODS:Linked transplantation and cancer registry data were used to identify incident cancers and deaths among solid organ transplant recipients in the United States (1987-2014). Population-attributable fractions (PAFs) of deaths due to cancer and corresponding cancer-attributable mortality rates were estimated using Cox models. RESULTS:Among 221,962 solid organ transplant recipients, 15,012 developed cancer. Approximately 13% of deaths (PAF, 13.2%) were attributable to cancer, corresponding to a cancer-attributable mortality rate of 516 per 100,000 person-years. Lung cancer was the largest contributor to mortality (PAF, 3.1%), followed by non-Hodgkin lymphoma (NHL; PAF, 1.9%), colorectal cancer (PAF, 0.7%), and kidney cancer (PAF, 0.5%). Cancer-attributable mortality rates increased with age at transplantation, reaching 1229 per 100,000 person-years among recipients aged ?65 years. NHL was the largest contributor among children (PAF, 4.1%) and lung cancer was the largest contributor among recipients aged ?50 years (PAFs, 3.7%-4.3%). Heart recipients had the highest PAF (16.4%), but lung recipients had the highest cancer-attributable mortality rate (1241 per 100,000 person-years). Overall, mortality attributable to cancer increased steadily with longer time since transplantation, reaching 15.7% of deaths (810 per 100,000 person-years) at ?10 years after transplantation. Comparison of cancer-attributable mortality rates with specified causes of death indicated that some deaths recorded as other causes might instead be caused by cancer or its treatment. CONCLUSIONS:Cancer is a substantial cause of mortality among solid organ transplant recipients, with major contributions reported from lung cancer and NHL. Cancer-attributable mortality increases with age and time since transplantation, and therefore cancer deaths will become an increasing burden as recipients live longer.

SUBMITTER: Noone AM 

PROVIDER: S-EPMC6625902 | biostudies-literature | 2019 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Cancer-attributable mortality among solid organ transplant recipients in the United States: 1987 through 2014.

Noone Anne-Michelle AM   Pfeiffer Ruth M RM   Dorgan Joanne F JF   Magder Laurence S LS   Bromberg Jonathan S JS   Lynch Charles F CF   Morris Cyllene R CR   Pawlish Karen S KS   Engels Eric A EA  

Cancer 20190429 15


<h4>Background</h4>Solid organ transplant recipients have an elevated risk of cancer. Quantifying deaths attributable to cancer can inform priorities to reduce cancer burden.<h4>Methods</h4>Linked transplantation and cancer registry data were used to identify incident cancers and deaths among solid organ transplant recipients in the United States (1987-2014). Population-attributable fractions (PAFs) of deaths due to cancer and corresponding cancer-attributable mortality rates were estimated usin  ...[more]

Similar Datasets

| S-EPMC6403005 | biostudies-literature
| S-EPMC3414043 | biostudies-literature
| S-EPMC4928388 | biostudies-other
| S-EPMC4261198 | biostudies-other
| S-EPMC4064001 | biostudies-literature
| S-EPMC5636643 | biostudies-literature
| S-EPMC7850530 | biostudies-literature
| S-EPMC6347016 | biostudies-literature